“The Association of HER-2 Over-expression in Relation to Hormonal Receptor Status and Common Clinico-pathological Parameters in Breast Carcinoma” (2019) Journal of Surgical Sciences, 16(2), pp. 59–67. doi:10.3329/jss.v16i2.43602.